Cartitude-5: A Randomized, Phase 3 Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Not Intended for Transplant

Saved in:
Bibliographic Details
Published inTransplantation and cellular therapy Vol. 28; no. 3; pp. S178 - S179
Main Authors Agha, Mounzer, Dhakal, Binod, Dytfeld, Dominik, Manier, Salomon, Delforge, Michel, Kuppens, Steven, Afifi, Salma, Deraedt, William, Taraseviciute-Morris, Agne, Schecter, Jordan M, Gilbert, Jane, Yalniz, Fevzi, Florendo, Erika, Pacaud, Lida, Hungria, Vania, Usmani, Saad Z., Mateos, Maria-Victoria
Format Journal Article
LanguageEnglish
Published 01.03.2022
Online AccessGet full text

Cover

More Information
ISSN:2666-6367
2666-6367
DOI:10.1016/S2666-6367(22)00381-5